These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1909530)

  • 1. Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain?
    Vandenabeele P; Fiers W
    Immunol Today; 1991 Jul; 12(7):217-9. PubMed ID: 1909530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alzheimer's disease, amyloidosis, microglia and astrocytes].
    Hauw JJ; Duyckaerts C; Delaere P; Chaunu MP
    Rev Neurol (Paris); 1988; 144(3):155-7. PubMed ID: 3285438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alzheimer dementia: more than amyloid plaques and neurofibrillary degeneration].
    Bauer J
    Fortschr Med; 1994 Mar; 112(7):81-4. PubMed ID: 8175096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 1-antichymotrypsin in brain aging and disease.
    Abraham CR; Potter H
    Prog Clin Biol Res; 1989; 317():1037-48. PubMed ID: 2513582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular nitric oxide, sex hormone replacement, and fish oil may help to prevent Alzheimer's disease by suppressing synthesis of acute-phase cytokines.
    McCarty MF
    Med Hypotheses; 1999 Nov; 53(5):369-74. PubMed ID: 10616034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes.
    Blasko I; Veerhuis R; Stampfer-Kountchev M; Saurwein-Teissl M; Eikelenboom P; Grubeck-Loebenstein B
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):682-9. PubMed ID: 11114266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid fragment potentiates IL-6 and TNF-alpha secretion by LPS in astrocytes but not in microglia.
    Forloni G; Mangiarotti F; Angeretti N; Lucca E; De Simoni MG
    Cytokine; 1997 Oct; 9(10):759-62. PubMed ID: 9344508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
    Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
    Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer's disease-related symptoms and pathology.
    Hao W; Liu Y; Liu S; Walter S; Grimm MO; Kiliaan AJ; Penke B; Hartmann T; Rübe CE; Menger MD; Fassbender K
    Brain; 2011 Jan; 134(Pt 1):278-92. PubMed ID: 21115468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease.
    Nagele RG; Wegiel J; Venkataraman V; Imaki H; Wang KC; Wegiel J
    Neurobiol Aging; 2004; 25(5):663-74. PubMed ID: 15172746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients.
    Ojala J; Alafuzoff I; Herukka SK; van Groen T; Tanila H; Pirttilä T
    Neurobiol Aging; 2009 Feb; 30(2):198-209. PubMed ID: 17658666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-6-mediated events in Alzheimer's disease pathology.
    Bauer J; Strauss S; Volk B; Berger M
    Immunol Today; 1991 Nov; 12(11):422. PubMed ID: 1786076
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta protein precursor expression in human platelets and a megakaryocyte cell line. Possible implications for the origin of cerebral amyloidosis in Alzheimer's disease.
    Gardella JE; Gorgone GA; Munoz PC; Ghiso J; Frangione B; Gorevic PD
    Lab Invest; 1992 Sep; 67(3):303-13. PubMed ID: 1405489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer's disease.
    Fiebich BL; Hüll M; Lieb K; Schumann G; Berger M; Bauer J
    J Neural Transm Suppl; 1998; 54():268-78. PubMed ID: 9850935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.
    Gómez-Tortosa E; Gonzalo I; Fanjul S; Sainz MJ; Cantarero S; Cemillán C; Yébenes JG; del Ser T
    Arch Neurol; 2003 Sep; 60(9):1218-22. PubMed ID: 12975286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice.
    Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE
    Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
    Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
    Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia and immune activation in Alzheimer's disease.
    Gordon MN
    J Fla Med Assoc; 1993 Apr; 80(4):267-70. PubMed ID: 7685046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.